Menu
GeneBe

rs34099398

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM1

The NM_000051.4(ATM):c.7999A>G(p.Met2667Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000267 in 1,608,074 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M2667L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:9

Conservation

PhyloP100: 5.28
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 17 uncertain in NM_000051.4

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATMNM_000051.4 linkuse as main transcriptc.7999A>G p.Met2667Val missense_variant 54/63 ENST00000675843.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATMENST00000675843.1 linkuse as main transcriptc.7999A>G p.Met2667Val missense_variant 54/63 NM_000051.4 P1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
151906
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000119
AC:
3
AN:
251050
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135712
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000268
AC:
39
AN:
1456168
Hom.:
0
Cov.:
30
AF XY:
0.0000235
AC XY:
17
AN XY:
724744
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000343
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
151906
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74222
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000589
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000334
Hom.:
0
Bravo
AF:
0.0000340
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ataxia-telangiectasia syndrome Uncertain:2
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Feb 18, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 18, 2024This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2667 of the ATM protein (p.Met2667Val). This variant is present in population databases (rs34099398, gnomAD 0.003%). This missense change has been observed in individual(s) with colorectal cancer or breast cancer (PMID: 19781682, 28135145). ClinVar contains an entry for this variant (Variation ID: 141559). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxSep 06, 2023Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Observed with a reportedly pathogenic ATM variant, phase (cis or trans) unknown, in a patient with colorectal cancer (Yurgelun et al., 2017); Observed in individuals with breast cancer, but also in healthy controls (Renwick et al., 2006; Tavtigian et al., 2009; Bhai et al., 2021); This variant is associated with the following publications: (PMID: 26787654, 26727500, 22529920, 33471991, 16832357, 34326862, 19781682, 28135145) -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2016- -
Familial cancer of breast Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterJun 23, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJun 30, 2023- -
Hereditary cancer-predisposing syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthDec 27, 2021This missense variant replaces methionine with valine at codon 2667 of the ATM protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with breast cancer and in unaffected individuals (PMID: 16832357, 19781682, 33471991; Color Health internal data). This variant also has been reported in an individual affected with colorectal cancer, although the individual was found to also have a co-occuring ATM germline mutation (PMID: 28135145). This variant has been identified in 4/282418 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 23, 2023The p.M2667V variant (also known as c.7999A>G), located in coding exon 53 of the ATM gene, results from an A to G substitution at nucleotide position 7999. The methionine at codon 2667 is replaced by valine, an amino acid with highly similar properties. This variant has been identified in multiple breast cancer cohorts as well and unaffected control groups across studies (Renwick A et al. Nat Genet, 2006 Aug;38:873-5; Tavtigian S et al. Am J Hum Genet. 2009 Oct;85(4):427-46; Young EL et al. J Med Genet, 2016 06;53:366-76; Dorling et al. N Engl J Med. 2021 02;384:428-439). This variant has been reported in an individual affected with colorectal cancer, who was also identified to carry a pathogenic mutation in ATM (Yurgelun MB et al. J Clin Oncol, 2017 Apr;35:1086-1095). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Breast and/or ovarian cancer Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioApr 02, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Uncertain
0.037
T
BayesDel_noAF
Benign
-0.12
Cadd
Benign
22
Dann
Benign
0.94
DEOGEN2
Benign
0.082
T;T
Eigen
Benign
0.097
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.82
T;.
M_CAP
Uncertain
0.20
D
MetaRNN
Uncertain
0.52
D;D
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
1.8
L;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.3
N;N
REVEL
Uncertain
0.37
Sift
Benign
0.33
T;T
Sift4G
Benign
0.68
T;T
Polyphen
0.18
B;B
Vest4
0.71
MVP
0.87
MPC
0.15
ClinPred
0.31
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.61
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34099398; hg19: chr11-108204684; COSMIC: COSV53730750; COSMIC: COSV53730750; API